发明名称 New 3-morpholino-3-phenyl-1-phenylsulfonyl-indolin-2-one derivatives, useful for treating arginine-vasopressin related disorders such as cardiovascular, central nervous system, renal or gastric disease
摘要 (3S)-4-(1-Phenylsulfonyl-3-phenyl-2-oxo-2,3-dihydro-1H-indol-3-yl)-mor pholine-3-carboxamide or -3-carboxylate ester derivatives (I) are new. Also new are non-sulfonylated intermediates (II). Indolinone derivatives of formula (I) and their solvates and/or hydrates (including the pure (3R) and (3S) optical isomers at the indole group) are new. R1 = H, 1-4C alkyl, CF3 or OCF3; R2 = H, halo, 1-4C alkyl, 1-4C alkoxy or CF3; or R1+R2 = 5,6-trimethylene; R3 = halo, OH, OMe or OEt; R4 = H, halo, Me, Et, OMe or OEt; or R3+R4 = 2,3-methylenedioxy; R5 = NHEt, NMe2, azetidino, OMe or OEt; R6, R7 = 1-4C alkoxy. Independent claims are also included for: (1) preparation of (I); and (2) new intermediates of formula (II), including their salts with mineral or organic acids, in pure optical isomer or diastereomer mixture form.
申请公布号 FR2804115(A1) 申请公布日期 2001.07.27
申请号 FR20000000958 申请日期 2000.01.25
申请人 SANOFI-SYNTHELABO 发明人 SCHOENTJES BRUNO;SERRADEIL LEGAL CLAUDINE;WAGNON JEAN
分类号 A61K31/5377;A61P1/00;A61P1/04;A61P1/08;A61P1/16;A61P3/04;A61P3/06;A61P3/10;A61P5/00;A61P9/00;A61P9/04;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P13/12;A61P15/08;A61P17/06;A61P19/02;A61P25/00;A61P25/06;A61P25/14;A61P25/16;A61P25/22;A61P25/24;A61P25/28;A61P27/06;A61P27/12;A61P29/00;A61P35/00;A61P37/04;A61P43/00;C07D413/04;(IPC1-7):C07D413/04;A61K31/537 主分类号 A61K31/5377
代理机构 代理人
主权项
地址